Biogen Inc Earnings, Revenue beat in Q4

Investing.com - Biogen Inc (NASDAQ:BIIB) reported fourth quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.

The firm reported earnings per share of $6.99 on revenue of $3.53B. Analysts polled by Investing.com forecast EPS of $6.73 on revenue of $3.39B. That compared to EPS of $5.26 on revenue of $3.31B in the same period a year earlier. The company had reported EPS of $7.4 on revenue of $3.44B in the previous quarter.

Biogen Inc follows other major Healthcare sector earnings this month

On January 22, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.

Abbott Labs earnings matched analyst's expectations on January 23, with fourth quarter EPS of $0.81 on revenue of $7.77B. Investing.com analysts expected EPS of $0.81 on revenue of $7.81B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

PayPal entry punishes Australia's pricey buy-now-pay-later stocks

Swiss watchdog opens enforcement case against Credit Suisse in spy affair